NL-OMON25640
Completed
Not Applicable
A prospective, open, randomized, multicenter study comparing the effects of everolimus versus mycophenolate sodium as compared to ciclosporin as maintenance therapy in renal allograft recipients, on chronic allograft damage and cardiovascular parameters.
MECANO Steering group Chair: S.Surachno/F.Bemelman0 sites255 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- prospective, open, randomized multicenter
- Sponsor
- MECANO Steering group Chair: S.Surachno/F.Bemelman
- Enrollment
- 255
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. First or second renal transplant;
- •2\. Female or male 18\-70 years;
Exclusion Criteria
- •1\. Double kidney transplants, kidney\-pancreas transplants, 3rd or 4th transplant;
- •2\. PRA \> 50% historic or current;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 4
A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCTChronic Graft-versus-host-diseaseLeukemia RelapseNCT03190733Zhujiang Hospital192
Recruiting
Not Applicable
A prospective, open-label, multicenter randomized phase-II trial to evaluate the efficacy and safety of a sequential regimen of obinutuzumab (Gazyvaro) followed by obinutuzumab and venetoclax, followed by either standard venetoclax maintenance or MRD guided venetoclax maintenance in first-line patients with CLL and unfit for FCR-like regimensChronic Lymphocytic Leukemia (CLL)NL-OMON23205HOVON data center70
Completed
Not Applicable
Mycophenolate sodium versus Everolimus or Cyclosporine with Allograft Nephropathy as OutcomeRenal transplantSurgeryTransplanted organs and tissue statusISRCTN69188731Academic Medical Center (AMC), Renal Transplant Unit (The Netherlands)255
Completed
Not Applicable
CAlciNeurin-inhibitor Nephrotoxicity and Efficacy StudyRenal transplantInjury, Occupational Diseases, PoisoningFailure and rejection of transplanted organs and tissuesISRCTN55817881eiden University Medical Centre (LUMC) (The Netherlands)126
Not yet recruiting
Phase 3
A prospective, randomized, open, multicenter study to evaluate the efficacy and tolerability of induction therapy with a single high-dose anti-T-lymphocyte globulin (ATG-Fresenius) in renal transplant patients with a kidney from a non-heart-beating donor and tacrolimus, mycophenolate mofetil, and steroids as basic immunosuppression.delayed graft functionacute rejction10038430NL-OMON30577Academisch Medisch Centrum180